Natalia Krawczyk
About
In The Last Decade
Natalia Krawczyk
38 papers receiving 682 citations
Peers
Comparison fields: 5 of 49
- Oncology 578
- Cancer Research 396
- Pulmonary and Respiratory Medicine 172
- Molecular Biology 142
- Biomedical Engineering 56
Countries citing papers authored by Natalia Krawczyk
This map shows the geographic impact of Natalia Krawczyk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Natalia Krawczyk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Natalia Krawczyk more than expected).
Fields of papers citing papers by Natalia Krawczyk
This network shows the impact of papers produced by Natalia Krawczyk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Natalia Krawczyk. The network helps show where Natalia Krawczyk may publish in the future.
Co-authorship network of co-authors of Natalia Krawczyk
This figure shows the co-authorship network connecting the top 25 collaborators of Natalia Krawczyk. A scholar is included among the top collaborators of Natalia Krawczyk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Natalia Krawczyk. Natalia Krawczyk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 1 | |
| 4 | 2 | |
| 5 | 4 | |
| 6 | 3 | |
| 7 | 1 | |
| 8 | 24 | |
| 9 | 3 | |
| 10 | 12 | |
| 11 | 35 | |
| 12 | 16 | |
| 13 | 30 | |
| 14 | 22 | |
| 15 | 21 | |
| 16 | 63 | |
| 17 | 18 | |
| 18 | HER2 status on persistent disseminated tumor cells after adjuvant therapy may differ from initial HER2 status on primary tumor. | 48 |
| 19 | 38 | |
| 20 | 19 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.